Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02008591
Other study ID # 2013P001927
Secondary ID
Status Completed
Phase Phase 4
First received November 26, 2013
Last updated January 20, 2017
Start date November 26, 2013
Est. completion date January 27, 2016

Study information

Verified date January 2017
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief.

The secondary objective of this study is to compare the fetal effects of these three epidural labor analgesia techniques.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date January 27, 2016
Est. primary completion date January 27, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- 1. Nulliparous (first baby) parturient 2. Singleton, vertex gestation at term (37-42 weeks) 3. Less than 5 cm dilation 4. Desires an epidural technique for labor analgesia

Exclusion Criteria:

- 1. Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes) 2. Any contraindication to the administration of an epidural technique 3. History of hypersensitivity or idiosyncratic reaction to local anesthetic or opioid medications 4. Current or historical evidence of a disease which may result in the risk of a cesarean delivery.

5. Evidence of anticipated fetal anomalies

Study Design


Related Conditions & MeSH terms

  • Labor Pain
  • Laboring Women Requesting Neuraxial Labor Analgesia

Intervention

Procedure:
Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Three different techniques, using the same medications (bupivacaine and fentanyl)

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal Outcomes Onset, quality, and duration of analgesia, occurrences of hypotension, bradycardia, pruritus, nausea, emesis. Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours
Secondary Fetal Outcomes Occurrence of fetal bradycardia or other heart rate changes, changes in fetal heart tracing patterns Participants will be followed for the duration of labor analgesia from initiation to delivery, an expected average of 12 hours